Autonomix Medical (AMIX) Gains from Investment Securities (2023 - 2024)
Autonomix Medical's (AMIX) quarterly Gains from Investment Securities came in at $3.0 million in Q1 2024, up 1400.0% on a QoQ basis from $200000.0 in Q4 2023.
Autonomix Medical (AMIX) Gains from Investment Securities (2023 - 2024) Analysis & Trends
Autonomix Medical (AMIX) has 2 years of Gains from Investment Securities data on file, last reported at $3.0 million in Q1 2024.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to $3.0 million in Q1 2024; TTM through Mar 2025 was $3.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $3.4 million, changed N/A from the prior year.
- Gains from Investment Securities for Q1 2024 stood at $3.0 million, up from $200000.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for AMIX reached as high as $3.0 million in Q1 2024 and fell as low as $200000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Autonomix Medical | 1.17 Mn | 1.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 3.00 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 239,000.00 |
| Sep 30, 2023 | 239,000.00 |